$149.4 M

MBII Mkt cap, 04-Dec-2018

$5.4 M

Marrone Bio Innovations Revenue Q3, 2018
Marrone Bio Innovations Net income (Q3, 2018)-4.4 M
Marrone Bio Innovations EBIT (Q3, 2018)-4.2 M
Marrone Bio Innovations Cash, 30-Sep-201820.5 M
Marrone Bio Innovations EV130.6 M

Marrone Bio Innovations Income Statement

Annual

USDFY, 2013Y, 2014FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

14.5m1.1m9.1m9.8m14.0m18.2m

Revenue growth, %

(92%)793%43%

General and administrative expense

15.0m29.0m26.5m18.5m19.8m

Operating expense total

32.8m48.2m40.0m28.2m30.6m

EBIT

(29.0m)(15.5m)(48.5m)(39.5m)(23.7m)(23.0m)

EBIT margin, %

(200%)(1416%)(531%)(403%)(168%)(127%)

Interest expense

6.0m669.0k2.9m2.8m2.9m3.4m

Interest income

49.0k17.0k59.0k51.0k37.0k1.0k

Pre tax profit

(28.5m)(16.2m)(51.7m)(43.7m)(31.1m)(30.9m)

Income tax expense

Net Income

(28.5m)(16.2m)(51.7m)(43.7m)(31.1m)(30.9m)

Marrone Bio Innovations Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

24.5m35.3m19.8m9.6m786.0k

Accounts Receivable

6.2m1.8m2.3m3.6m3.8m

Inventories

11.7m12.6m9.1m8.5m9.8m

Current Assets

58.7m54.7m36.0m26.9m19.1m

PP&E

9.4m20.2m18.4m17.3m16.0m

Total Assets

68.9m77.2m71.8m46.0m36.9m

Accounts Payable

4.5m5.8m2.0m1.4m3.8m

Short-term debt

157.0k12.6m267.0k1.5m

Current Liabilities

11.7m31.2m12.9m15.2m22.0m

Long-term debt

Total Debt

157.0k12.6m267.0k1.5m

Total Liabilities

27.1m44.0m73.8m76.2m87.6m

Preferred Stock

Additional Paid-in Capital

147.2m193.1m201.6m204.5m214.9m

Retained Earnings

(105.4m)(159.8m)(203.6m)(234.6m)(265.6m)

Total Equity

41.8m33.2m(2.0m)(30.2m)(50.7m)

Debt to Equity Ratio

-0.1 x

Debt to Assets Ratio

0 x

Financial Leverage

1.6 x2.3 x-35.5 x-1.5 x-0.7 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

40.8m21.3m57.6m22.4m12.2m27.8m9.8m21.2m16.0m1.8m10.2m3.7m14.8m23.3m20.5m

Accounts Receivable

2.1m7.2m4.1m2.2m3.0m1.4m4.7m4.5m2.1m8.1m5.8m1.9m4.4m4.7m3.1m

Inventories

10.8m12.8m12.5m11.8m10.6m9.8m8.6m8.0m8.4m8.1m8.4m9.3m10.0m9.2m8.8m

Current Assets

68.6m47.0m80.1m41.1m30.2m43.4m28.1m37.8m30.6m24.4m29.6m19.5m30.4m38.0m33.8m

PP&E

5.7m15.8m18.5m20.1m20.1m19.3m19.1m18.5m17.9m16.9m16.5m16.2m15.7m15.3m14.9m

Total Assets

75.4m63.5m101.0m63.4m52.5m80.1m64.0m58.2m50.2m43.0m47.8m37.4m48.0m55.1m50.5m

Accounts Payable

5.1m8.6m5.2m4.1m3.2m1.0m2.6m2.2m2.2m3.0m3.2m2.7m2.6m1.5m1.9m

Short-term debt

177.0k123.0k340.0k12.7m12.7m259.0k242.0k244.0k248.0k249.0k3.0m1.7m1.9m2.6m1.7m

Current Liabilities

10.2m14.5m11.4m28.6m27.7m11.5m13.4m13.8m12.6m18.6m21.7m28.1m11.6m10.4m9.9m

Total Debt

177.0k123.0k340.0k12.7m12.7m259.0k242.0k244.0k248.0k249.0k3.0m1.7m1.9m2.6m1.7m

Total Liabilities

25.0m29.5m36.0m41.0m40.0m72.0m74.7m74.9m73.5m80.2m83.5m81.1m34.3m33.2m32.5m

Additional Paid-in Capital

145.9m149.6m191.1m194.2m195.3m200.6m202.2m202.9m203.6m205.1m214.0m214.5m279.9m293.0m293.5m

Retained Earnings

(95.4m)(115.7m)(126.1m)(171.8m)(182.7m)(192.5m)(212.9m)(219.6m)(226.8m)(242.3m)(249.7m)(258.2m)(266.2m)(271.0m)(275.5m)

Total Equity

50.4m34.0m65.0m22.4m12.5m8.1m(10.7m)(16.7m)(23.2m)(37.2m)(35.6m)(43.7m)13.8m22.0m18.0m

Debt to Equity Ratio

1 x0 x0.1 x0.1 x

Debt to Assets Ratio

0.2 x0 x0 x0 x

Financial Leverage

1.5 x1.9 x1.6 x2.8 x4.2 x9.9 x-6 x-3.5 x-2.2 x-1.2 x-1.3 x-0.9 x3.5 x2.5 x2.8 x

Marrone Bio Innovations Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(28.5m)(51.7m)(43.7m)(31.1m)(30.9m)

Depreciation and Amortization

976.0k2.6m3.5m2.2m2.0m

Accounts Receivable

(3.4m)2.0m(560.0k)(1.2m)(193.0k)

Inventories

(6.8m)73.0k3.6m582.0k(1.3m)

Accounts Payable

1.7m1.7m(3.5m)(588.0k)2.3m

Cash From Operating Activities

(34.0m)(35.9m)(36.2m)(24.3m)(21.1m)

Purchases of PP&E

(4.0m)(13.0m)(1.7m)(209.0k)(849.0k)

Cash From Investing Activities

(17.7m)671.0k(1.6m)(209.0k)(814.0k)

Long-term Borrowings

(9.4m)(378.0k)(435.0k)(260.0k)(756.0k)

Cash From Financing Activities

66.1m46.1m22.3m14.3m13.0m

Marrone Bio Innovations Ratios

USDY, 2018

EV/EBIT

-31.5 x

EV/CFO

-7.8 x

Financial Leverage

2.8 x
Report incorrect company information

Marrone Bio Innovations Employee Rating

2.646 votes
Culture & Values
2.8
Work/Life Balance
3.5
Senior Management
2.5
Salary & Benefits
3.0
Career Opportunities
2.7
Source